The First Medical Center of Chinese PLA General Hospital
12
6
7
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.4% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia
Role: collaborator
AI-Based Screening and Diagnostic Models for Femoroacetabular Impingement Syndrome (FAIS-AI)
Role: collaborator
Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA
Role: collaborator
Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment
Role: collaborator
Beta-Blockers on Neoadjuvant Immunochemotherapy for Hypertensive Patients With Gastric Cancer
Role: collaborator
A Study About Remote and Local Liver Surgery
Role: collaborator
Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy
Role: collaborator
Microbial Colonization Distribution and Adaptive Evolution of Lower Respiratory Tract in Bronchiectasis Patients.
Role: collaborator
Bacteriophage Cocktail Therapy for Multidrug-Resistant Gram-Negative Ventilator-Associated Pneumonia
Role: collaborator
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Role: collaborator
Predictive Ability of Different Frailty Indices for Postoperative Infections in Elderly Patients
Role: collaborator
Comparison of Conservative and Endovascular Treatment for Spontaneously Isolated Superior Mesenteric Artery Dissection
Role: collaborator
All 12 trials loaded